Summary

The U.S. prosthetic heart valve market was valued at $3.2 billion in 2023, and is projected to reach $8.9 billion by 2033, growing at a CAGR of 10.7% from 2024 to 2033.
Prosthetic heart valve is a medical device implanted in the heart to replace a diseased or damaged valve that cannot regulate blood flow effectively. These artificial valves are designed to mimic the function of natural heart valves, ensuring proper one-way blood flow through the heart and preventing leakage. Prosthetic heart valves are primarily used to treat conditions such as valve stenosis (narrowing) or valve regurgitation (leakage), which can compromise heart function and overall health.

The growth of the U.S. prosthetic heart valve market is driven by alarming rise in the prevalence of cardiovascular conditions such as aortic stenosis and mitral regurgitation. According to a study published by the Centers for Disease Control and Prevention in 2024, heart disease is the leading cause of death in the U.S., resulting in 702,880 deaths in 2022. The study further highlighted that one individual dies every 33 seconds due to cardiovascular disease. This highlights the urgent need for prosthetic heart valves, thus augmenting the market growth. In addition, surge in geriatric population significantly contributes toward the market growth. This is attributed to the fact that this demographic has a higher susceptibility to heart valve degeneration. As per the 2024 data recorded by the Population Reference Bureau, the number of Americans aging 65 years and older was 58 million in 2022, and is estimated to reach 82 million by 2050. Furthermore, increase in awareness of screening programs acts as the key driving force of the market. For instance, the Million Hearts® is a national initiative co-led by the Centers for Disease Control and Prevention, which focuses on preventing 1 million heart attacks and strokes within 5 years. Moreover, rise in adoption of minimally invasive procedures and supportive reimbursement policies strengthen the market growth. However, high costs of prosthetic valves and procedures acts as the key deterrent factor of the market. In addition, risk of post-surgical complications such as thrombosis, structural valve degeneration, and endocarditis restrains the market growth. On the contrary, innovations such as transcatheter aortic valve replacement have revolutionized treatment, offering minimally invasive options for patients who are high-risk for open-heart surgery. Such developments are expected to offer lucrative opportunities for the expansion of the market during the forecast period.

The U.S. prosthetic heart valve market is segmented on the basis of product. By product, the market is categorized into mechanical heart valve, tissue heart valve, and transcatheter heart valve. The tissue heart valve segment is further classified into stented tissue heart valve and stent less tissue heart valve.
Key Findings
The transcatheter heart valve segment generated the largest revenue in U.S. prosthetic heart valve market share in 2023, and is expected to continue the same trend from 2024 to 2033.

Competition Analysis
Competitive analysis and profiles of the major players in the global U.S. prosthetic heart valve market include Abbott Laboratories, Artivion, Inc, Anteris Technologies Ltd, Boston Scientific Corporation, Edward Lifesciences Corporation, JenaValve Technology, Inc., Colibri Heart Valve, Medtronic plc, Meril Life Sciences Pvt. Ltd., and ShockWave Medical, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the competitive market.

Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● Regulatory Guidelines
● Additional company profiles with specific to client's interest
● Additional country or region analysis- market size and forecast
● Expanded list for Company Profiles
● Historic market data
● Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Product
● Tissue Heart Valve
○ Stented Tissue Heart Valve
○ Stentless Tissue Heart Valve
● Mechanical Heart Valve
● Transcatheter Heart Valve
● Key Market Players
○ Abbott Laboratories
○ Artivion, Inc
○ Anteris Technologies Ltd
○ Boston Scientific Corporation
○ Edward Lifesciences Corporation
○ JenaValve Technology, Inc.
○ Colibri Heart Valve
○ Medtronic plc
○ Meril Life Sciences Pvt. Ltd.
○ ShockWave Medical, Inc.

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: U.S. PROSTHETIC HEART VALVE MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Tissue Heart Valve
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Stented Tissue Heart Valve
4.2.3. Stentless Tissue Heart Valve
4.3. Mechanical Heart Valve
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.4. Transcatheter Heart Valve
4.4.1. Key Market Trends, Growth Factors and Opportunities
CHAPTER 5: COMPETITIVE LANDSCAPE
5.1. Introduction
5.2. Top Winning Strategies
5.3. Product Mapping Of Top 10 Player
5.4. Competitive Dashboard
5.5. Competitive Heatmap
5.6. Top Player Positioning,2023
CHAPTER 6: COMPANY PROFILES
6.1. Abbott Laboratories
6.1.1. Company Overview
6.1.2. Key Executives
6.1.3. Company Snapshot
6.1.4. Operating Business Segments
6.1.5. Product Portfolio
6.1.6. Business Performance
6.1.7. Key Strategic Moves and Developments
6.2. Artivion, Inc
6.2.1. Company Overview
6.2.2. Key Executives
6.2.3. Company Snapshot
6.2.4. Operating Business Segments
6.2.5. Product Portfolio
6.2.6. Business Performance
6.2.7. Key Strategic Moves and Developments
6.3. Anteris Technologies Ltd
6.3.1. Company Overview
6.3.2. Key Executives
6.3.3. Company Snapshot
6.3.4. Operating Business Segments
6.3.5. Product Portfolio
6.3.6. Business Performance
6.3.7. Key Strategic Moves and Developments
6.4. Boston Scientific Corporation
6.4.1. Company Overview
6.4.2. Key Executives
6.4.3. Company Snapshot
6.4.4. Operating Business Segments
6.4.5. Product Portfolio
6.4.6. Business Performance
6.4.7. Key Strategic Moves and Developments
6.5. Edward Lifesciences Corporation
6.5.1. Company Overview
6.5.2. Key Executives
6.5.3. Company Snapshot
6.5.4. Operating Business Segments
6.5.5. Product Portfolio
6.5.6. Business Performance
6.5.7. Key Strategic Moves and Developments
6.6. JenaValve Technology, Inc.
6.6.1. Company Overview
6.6.2. Key Executives
6.6.3. Company Snapshot
6.6.4. Operating Business Segments
6.6.5. Product Portfolio
6.6.6. Business Performance
6.6.7. Key Strategic Moves and Developments
6.7. Colibri Heart Valve
6.7.1. Company Overview
6.7.2. Key Executives
6.7.3. Company Snapshot
6.7.4. Operating Business Segments
6.7.5. Product Portfolio
6.7.6. Business Performance
6.7.7. Key Strategic Moves and Developments
6.8. Medtronic Plc
6.8.1. Company Overview
6.8.2. Key Executives
6.8.3. Company Snapshot
6.8.4. Operating Business Segments
6.8.5. Product Portfolio
6.8.6. Business Performance
6.8.7. Key Strategic Moves and Developments
6.9. Meril Life Sciences Pvt. Ltd.
6.9.1. Company Overview
6.9.2. Key Executives
6.9.3. Company Snapshot
6.9.4. Operating Business Segments
6.9.5. Product Portfolio
6.9.6. Business Performance
6.9.7. Key Strategic Moves and Developments
6.10. ShockWave Medical, Inc.
6.10.1. Company Overview
6.10.2. Key Executives
6.10.3. Company Snapshot
6.10.4. Operating Business Segments
6.10.5. Product Portfolio
6.10.6. Business Performance
6.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. U.S. PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 2. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 3. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 4. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 5. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 6. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 7. ARTIVION, INC: KEY EXECUTIVES
TABLE 8. ARTIVION, INC: COMPANY SNAPSHOT
TABLE 9. ARTIVION, INC: OPERATING SEGMENTS
TABLE 10. ARTIVION, INC: PRODUCT PORTFOLIO
TABLE 11. ARTIVION, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 12. ANTERIS TECHNOLOGIES LTD: KEY EXECUTIVES
TABLE 13. ANTERIS TECHNOLOGIES LTD: COMPANY SNAPSHOT
TABLE 14. ANTERIS TECHNOLOGIES LTD: OPERATING SEGMENTS
TABLE 15. ANTERIS TECHNOLOGIES LTD: PRODUCT PORTFOLIO
TABLE 16. ANTERIS TECHNOLOGIES LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 17. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 18. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 19. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 20. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 21. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 22. EDWARD LIFESCIENCES CORPORATION: KEY EXECUTIVES
TABLE 23. EDWARD LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 24. EDWARD LIFESCIENCES CORPORATION: OPERATING SEGMENTS
TABLE 25. EDWARD LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 26. EDWARD LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 27. JENAVALVE TECHNOLOGY, INC.: KEY EXECUTIVES
TABLE 28. JENAVALVE TECHNOLOGY, INC.: COMPANY SNAPSHOT
TABLE 29. JENAVALVE TECHNOLOGY, INC.: OPERATING SEGMENTS
TABLE 30. JENAVALVE TECHNOLOGY, INC.: PRODUCT PORTFOLIO
TABLE 31. JENAVALVE TECHNOLOGY, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 32. COLIBRI HEART VALVE: KEY EXECUTIVES
TABLE 33. COLIBRI HEART VALVE: COMPANY SNAPSHOT
TABLE 34. COLIBRI HEART VALVE: OPERATING SEGMENTS
TABLE 35. COLIBRI HEART VALVE: PRODUCT PORTFOLIO
TABLE 36. COLIBRI HEART VALVE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 37. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 38. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 39. MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 40. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 41. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 42. MERIL LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
TABLE 43. MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
TABLE 44. MERIL LIFE SCIENCES PVT. LTD.: OPERATING SEGMENTS
TABLE 45. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
TABLE 46. MERIL LIFE SCIENCES PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 47. SHOCKWAVE MEDICAL, INC.: KEY EXECUTIVES
TABLE 48. SHOCKWAVE MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 49. SHOCKWAVE MEDICAL, INC.: OPERATING SEGMENTS
TABLE 50. SHOCKWAVE MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 51. SHOCKWAVE MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. U.S. PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 2. SEGMENTATION OF U.S. PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN U.S. PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: U.S. PROSTHETIC HEART VALVE MARKET
FIGURE 10. U.S. PROSTHETIC HEART VALVE MARKET , BY PRODUCT,2024 - 2033 ($BILLION)
FIGURE 11. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 12. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 13. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 14. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 15. COMPETITIVE DASHBOARD
FIGURE 16. COMPETITIVE HEATMAP: U.S. PROSTHETIC HEART VALVE MARKET
FIGURE 17. TOP PLAYER POSITIONING,2023
FIGURE 18. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 19. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 20. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 21. ARTIVION, INC: NET SALES, 2021-2023 ($BILLION)
FIGURE 22. ARTIVION, INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 23. ARTIVION, INC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 24. ANTERIS TECHNOLOGIES LTD: NET SALES, 2021-2023 ($BILLION)
FIGURE 25. ANTERIS TECHNOLOGIES LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 26. ANTERIS TECHNOLOGIES LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 27. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 28. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. EDWARD LIFESCIENCES CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 31. EDWARD LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. EDWARD LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. JENAVALVE TECHNOLOGY, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 34. JENAVALVE TECHNOLOGY, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. JENAVALVE TECHNOLOGY, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. COLIBRI HEART VALVE: NET SALES, 2021-2023 ($BILLION)
FIGURE 37. COLIBRI HEART VALVE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. COLIBRI HEART VALVE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. MEDTRONIC PLC: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. MERIL LIFE SCIENCES PVT. LTD.: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. SHOCKWAVE MEDICAL, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 46. SHOCKWAVE MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. SHOCKWAVE MEDICAL, INC.: REVENUE SHARE, BY REGION, 2023 (%)